Role of FDG PET-CT in the treatment management of Hodgkin lymphoma

被引：7

作者：

Berriolo-Riedinger, A. ^{[1
]}

Becker, S. ^{[2
]}

Casasnovas, O. ^{[3
,4
]}

Borght, T. Vander ^{[5
,6
]}

Edeline, V. ^{[7
]}

机构：

[1] Ctr Georges Francois Leclerc, Dept Nucl Med, 1 Rue Pr Marion, F-21000 Dijon, France

[2] Ctr Henri Becquerel, Dept Nucl Med, 1 Rue Amiens, F-76038 Rouen, France

[3] CHU F Mitterrand, Dept Hematol, F-21000 Dijon, France

[4] INSERM, UMR 1231, F-21000 Dijon, France

[5] CHU UCL Namur, Dept Nucl Med, Rue Dr Gaston Therasse 1, B-5530 Yvoir, Belgium

[6] Namur Res Inst Life Sci Narilis, Rue Bruxelles 61, B-5000 Namur, Belgium

[7] Hop Rene Huguenin, Inst Curie, Dept Nucl Med, 35 Rue Dailly, F-92210 St Cloud, France

来源：

CANCER RADIOTHERAPIE | 2018年 / 22卷 / 05期

关键词：

PET-CT; Hodgkin lymphoma; Interim PET; POSITRON-EMISSION-TOMOGRAPHY; RESPONSE-ADAPTED THERAPY; INTERNATIONAL HARMONIZATION PROJECT; METABOLIC TUMOR VOLUME; B-CELL LYMPHOMA; INTERIM-PET; WHOLE-BODY; FOLLOW-UP; BONE-MARROW; INTERPRETATION CRITERIA;

D O I：

10.1016/j.canrad.2018.06.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Fluorodeoxyglucose (FDG) positons emission tomography (PET)-computed tomography (CT) is used in many ways at baseline and during the treatment of patients with Hodgkin lymphoma. Many properties of the technique are used in the different steps of patient's management. Initial staging with PET-CT is more accurate than conventional imaging and PET-CT also became the gold standard imaging at the end of treatment with a negative PET-CT mandatory for reaching a complete remission. Early assessment of response by PET-CT is one of the most powerful prognostic factors for progression-free survival of patients with localized and advanced stages and allows guiding treatment. Conversely, previous studies showed that there is no role of FDG PET-CT for the patient's follow-up. (C) 2018 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：393 / 400

页数：8

共 50 条

[1] Role of FDG PET-CT in restaging of Hodgkin's lymphoma
Mohapatra, Tushar
Shamim, S. A.
Kumari, Anita
Kumar, Rakesh
Sellam, K.
Bal, Chandershekhar
Malhotra, A.
[J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
[2] Role of FDG-PET/CT in management of Hodgkin’s lymphoma
Arun Kumar Gupta
Devasenathipathy Kandasamy
Rachna Seth
[J]. The Indian Journal of Pediatrics, 2009, 76 : 1273 - 1274
[3] Role of FDG-PET/CT in Management of Hodgkin's Lymphoma
Gupta, Arun Kumar
Kandasamy, Devasenathipathy
Seth, Rachna
[J]. INDIAN JOURNAL OF PEDIATRICS, 2009, 76 (12): : 1273 - 1274
[4] FDG PET-CT in the Management of Primary Breast Lymphoma
Santra, Amburanjan
Kumar, Rakesh
Reddy, Ramamohan
Halanaik, Dhanapathi
Kumar, Rajender
Bal, Chandra Sekhar
Malhotra, Arun
[J]. CLINICAL NUCLEAR MEDICINE, 2009, 34 (12) : 848 - 853
[5] PET-CT: reliable cornerstone for Hodgkin lymphoma treatment?
Zijlstra, Josee E. M.
[J]. BLOOD, 2016, 127 (12) : 1521 - 1522
[6] Value of FDG PET-CT in the therapy evaluation of Hodgkin's lymphoma
Tuncel, M.
Kutluk, T. M.
Kiratli, P. O.
Aydin, B. G.
Erbas, B.
Akyuz, C.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S207 - S207
[7] The role of FDG PET/CT in the management of extranodal non-Hodgkin lymphoma
Bural, Gonca
Oborski, Matthew
Mountz, James
[J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54
[8] F-18 FDG PET/PET-CT in the management of lymphoma
Dhanapathi, Halanaik
Kumar, Rakesh
[J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (03) : 17 - 23
[9] Impact of FDG PET-CT in the staging and management of follicular lymphoma
Metser, Ur
Hussey, Douglas
Murphy, Grainne
[J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
[10] FDG PET-CT parameters in the therapy evaluation of patients with Hodgkin's lymphoma
Tuncel, M.
Kutluk, T. M.
Kiratli, P. O.
Aydin, B.
Erbas, B.
Akyuz, C.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S203 - S203

← 1 2 3 4 5 →